Translational/Clinical Research Support and Partnerships
HSRLCE is integrated with every teaching hospital engaged in cardiovascular research at University of Toronto. We have established support nodes in:
Network for Innovation in Clinical Research (U of T): Birthed as a result of a University of Toronto’s initiative to conduct single and multicentre trials under the leadership of the University’s cardiovascular clinical investigators. Membership encompasses all the University’s cardiovascular partners. NICR’s activities are broadly divided into 5 major categories: clinical trials; registries and observational studies; core laboratory functions; adjudication committees; and continuing medical education.
Cardiovascular Data Management Centre (Sick Kids): Serves the cardiovascular disease community by forging linkages between databases, providing access to the data for researchers and clinicians, providing risk adjusted reports for clinical quality improvement initiatives, and by providing statistical services to participants.
Cardiovascular Biobank (UHN/Mount Sinai): The mission is to establish and maintain a standardized approach to human specimen accrual, management, distribution and use for research purposes. The objective is to improve accessibility for our researchers to blood and tissue specimens from patients suffering from cardiac and vascular disease and to create a framework that promotes appropriate standards of quality and security.
Athlete’s Heart Laboratory (St. Michael’s Hospital/U of T):The general objectives of the Athlete’s Heart Group are to examine the impact of long-standing, excessive endurance exercise on cardiac remodeling, providing the basis for a long-term follow-up study to identify specific factors contributing to development of atrial fibrillation in middle-aged endurance athletes. A broader goal for the Group is to secure significant funding to fully develop an Athlete’s Heart Centre that includes a sports cardiology clinic, national registry and a core program of research focused on cardiac remodeling, arrhythmia risk and primary/secondary prevention.
Microvascular Research (St. Michael’s Hospital/U of T): Mandate of the Toronto Centre for Microvascular Medicine is to translate existing knowledge, concepts and techniques from animal models directly to human tissues and then on to clinical treatment. The goal is to correlate changes in human microvascular function with a specific disease process in patients, thereby making the first real in-road into ‘personalized medicine’.
Large Animal Facility (Sunnybrook): Focuses on the integration of large animal models of cardiovascular diseases with novel imaging modalities. Research at the clinic includes various forms of vascular disease (chronic total occlusions and atherosclerosis) and myocardial damage.
Transgenic Physiology Laboratory (U of T): Mandates of the platform are to provide mouse cardiac physiological assessment of mice, to generate mouse models of disease, and to allow acute genetic manipulation of mice as well as mouse tissues/cultures using viral-based gene transfer methods.